Impact of clinical trial virtualization on recruitment in underserved communities for a type 2 diabetes mHealth intervention
- 3 February 2026
- journal article
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 162, 108250
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (1 R01 DK113189-01A1)
- U.S. National Library of Medicine (T15LM007079)
This publication has 42 references indexed in Scilit:
- The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-Blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVIDThe American Journal of Medicine, 2024
- Telehealth Experience Among Patients With Limited English ProficiencyJAMA Network Open, 2024
- A Review of the Evolving Landscape of Inclusive Research and Improved Clinical Trial AccessClinical Pharmacology & Therapeutics, 2023
- Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical TrialsJAMA Network Open, 2021
- The New Normal in Clinical Trials: Decentralized StudiesAnnals of Neurology, 2020
- Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized PotentialNeurotherapeutics, 2020
- Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical TrialsJAMA Cardiology, 2020
- Can AI Help Reduce Disparities in General Medical and Mental Health Care?AMA Journal of Ethics, 2019
- Mobile Health Interventions for Improving Health Outcomes in YouthJAMA Pediatrics, 2017
- Under-representation of elderly and women in clinical trialsInternational Journal of Cardiology, 2017